Cre activity causes widespread apoptosis and lethal anemia during embryonic development

Genesis

Volumn 45, Issue 12, 2007, Pages 768-775

  Naiche, L A ^a   Papaioannou, Virginia E ^a,b  

^a Columbia University ^*  (United States)

^b HHSC 1402 ^*  (United States)

Author keywords

Apoptosis; Cre; Cre toxicity; Mouse development; Recombinase

Indexed keywords

CRE RECOMBINASE;

ALLELE; ANEMIA; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EMBRYO; EMBRYO DEVELOPMENT; GENE TARGETING; GENETIC ANALYSIS; HEMATOPOIESIS; LETHALITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANEMIA; ANIMALS; APOPTOSIS; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; HEMATOPOIESIS; INTEGRASES; MICE; MICE, TRANSGENIC;

EID: 38549123928     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20353     Document Type: Article

References (33)

1. Abremski K, Wierzbicki A, Frommer B, Hoess RH. 1986. Bacteriophage P1 Cre-loxP site-specific recombination. J Biol Chem 261:391-396.
2. Ahn K, Mishina Y, Hanks MC, Behringer RR, Crenshaw EB III. 2001. BMPR-IA signaling is required for the formation of the apical ectodermal ridge and dorsal-ventral patterning of the limb. Development 128:4449-4461.
3. Badea TC, Wang Y, Nathans J. 2003. A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse. J Neurosci 23:2314-2322.
4. Baron MH, Fraser ST. 2005. The specification of early hematopoiesis in the mammal. Curr Opin Hematol 12:217-221.
5. Branda CS, Dymecki SM. 2004. Talking about a revolution: The impact of site-specific recombinases on genetics analyses in mice. Dev Cell 6:7-28.
6. Buchholz F, Stewart AF. 2001. Alteration of Cre recombinase site specificity by substrate-linked protein evolution. Nat Biotechnol 19:1047-1052.
7. Buerger A, Rozhitskaya O, Sherwood MC, Dorfman AL, Bisping E, Abel ED, Pu WT, Izumo S, Jay PY. 2006. Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. J Card Fail 12:392-398.
8. Chapman DL, Garvey N, Hancock S, Alexiou M, Agulnik SI, Gibson-Brown JJ, Cebra-Thomas J, Bollag RJ, Silver LM, Papaioannou VE. 1996. Expression of the T-box family genes. Tbx1-Tbx5, during early mouse development. Dev Dyn 206:379-390.
9. de Luca C, Kowalski TJ, Zhang Y, Elmquist JK, Lee C, Kilimann MW, Ludwig T, Liu SM, Chua SC Jr. 2005. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J Clin Invest 115:3484-3493.
10. Forni PE, Scuoppo C, Imayoshi I, Taulli R, Dastru W, Sala V, Betz UAK, Muzzi P, Martinuzzi D, Vericelli A, Kageyama R, Ponzetto C. 2006. High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydroencephaly. J Neurosci 26:9593-9602.
11. Francis R, Richardson C. 2007. Multipotent hematopoietic cells susceptible to alternative double-strand break repair pathways that promote genome rearrangements. Genes Dev 21:1064-1074.
12. Furuta Y, Behringer R. 2005. Recent innovations in tissue-specific gene modifications in the mouse. Birth Defects Res C Embryo Today 75:43-57.
13. Gekas C, Dieterlen-Lièvre F, Orkin SH, Mikkola HKA. 2005. The placenta is a niche for hematopoietic stem cells. Dev Cell 8:365-375.
14. Gibson-Brown JJ, Agulnik SI, Chapman DL, Alexiou M, Garvey N, Silver LM, Papaioannou VE. 1996. Evidence of a role for T-box genes in the evolution of limb morphogenesis and the specification of forelimb/hindlimb identity. Mech Dev 56:93-101.
15. Hayashi S, McMahon AP. 2002. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: A tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 244:305-318.
16. Lee J, Ristow M, Lin X, White MF, Magnuson MA, Hennighausen L. 2006. RIP-cre revisited, evidence for impairments of pancreatic β-cell function. J Biol Chem 281:2649-2653.
17. Lewandoski M. 2001. Conditional control of gene expression in the mouse. Nat Rev Genet 2:743-755.
18. Logan M, Martin JF, Nagy A, Lobe C, Olson EN, Tabin C. 2002. Expression of Cre recombinase in the developing mouse limb bud driven by a Prx1 enhancer. Genesis 33:77-80.
19. Loonstra A, Vooijs M, Beverloo HB, Allak BA, van Drunen E, Kanaar R, Berns A, Jonkers J. 2001. Growth inhibition and DNA damage induced by Cre recombinase in mammahan cells. Proc Natl Acad Sci USA 98:9209-9214.
20. Naiche LA, Papaioannou VE. 2007. Tbx4 is not required for hindlimb identity or post-bud hindlimb outgrowth. Development 134:93-103.
21. Narushima M, Kobayashi N, Okitsu T, Tanaka Y, Li SA, Chen Y, Miki A, Tanaka K, Nakaji S, Takei K, Gutierrez AS, Rivas-Carrillo JD, Navarro-Alvarez N, Jun HS, Westerman KA, Noguchi H, Lakey JRT, Leboulch P, Tanaka N, Yoon JW. 2005. A human β-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol 23:1274-1282.
22. Okita K, Ichisaka T, Yamanaka S. 2007. Generation of germline-competent induced pluripotent stem cells. Nature 448:313-318.
23. Ottersbach K, Dzierzak E. 2005. The murine placenta contains hematopoietic stem cell within the vascular labyrinth region. Dev Cell 8:377-387.
24. Pfeifer A, Brandon EP, Kootstra N, Gage FG, Verma IM. 2001. Delivery of the Cre recombinase by a self-deleting lentiviral vector: Efficient gene targeting in vivo. Proc Natl Acad Sci USA 98:11450-11455.
25. Sarkar I, Hauber I, Hauber J, Buchholz F. 2007. HIV-1 proviral DNA excision using an evolved recombinase. Science 316:1912-1915.
26. Schaefer KS, Doughman YQ, Fisher SA, Watanabe M. 2004. Dynamic patterns of apoptosis in the developing chicken heart. Dev Dyn 229:489-499.
27. Schmidt EE, Taylor DS, Prigge JR, Barnett S, Capecchi MR. 2000. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc Natl Acad Sci USA 97:13702-13707.
28. Seibler J, Zevnik B, Küter-Luks B, Andreas S, Kern H, Hennek T, Rode A, Heimann C, Faust N, Kauselmann G, Schoor M, Jaenisch R, Rajewsky K, Kühn R, Schwenk F. 2003. Rapid generation of inducible mouse mutants. Nucleic Acids Res 31:e12.
29. Semprini S, Troup TJ, Kotelevtseva N, King K, Davis JRE, Mullins LJ, Chapman KE, Dunbar DR, Mullins JJ. 2007. Cryptic loxP sites in mammalian genomes: Genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques. Nucleic Acids Res 35:1402-1410.
30. Silver DR Livingston DM. 2001. Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated celular toxicity. Mol Cell 8:233-243.
31. Sternberg N, Hamilton D. 1981. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J Mol Biol 150:467-486.
32. Thyagarajan B, Guimarães AC, Groth AC, Calos MP. 2000. Mammalian genomes contain active recombinase recognition sites. Gene 244:47-54.
33. Zucker RM, Hunter S, Rogers JM. 1998. Confocal laser scanning microscopy of apoptosis in organogenesis-stage mouse embryos. Cytometry 33:348-354.